Recruiting NA INTERVENTIONAL 3-arm
NCT07164300
Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery
Comparative Study of Tranexamic Acid Dosage Regimens in Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass
Sponsor: University of Ioannina
Conditions
Adverse Drug Event Blood Coagulation Disorder Fibrinolysis; Hemorrhage Postoperative Blood Loss Tranexamic Acid Adverse Reaction
Interventions
Tranexamic acid at a dose of 10 mg/kg followed by 1 mg/kg/h Tranexamic acid at a dose of 20 mg/kg Tranexamic acid at a dose of 30 mg/kg
Updated 1 time since 2025 Last updated: Sep 5, 2025 Started: May 14, 2024 Primary completion: Dec 15, 2027 Completion: Dec 15, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Adverse Drug Event and Blood Coagulation Disorder and is currently actively recruiting participants. University of Ioannina leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University of Ioannina
Data source: University of Ioannina
For direct contact, visit the study record on ClinicalTrials.gov .